# EDGAR Filing Document

**Accession Number:** 0001831270
**File Stem:** 0001104659-23-005390
**Filing Date:** 2023-1
**Character Count:** 6350
**Document Hash:** bb80910b33fefec297ab89ba2c201f4d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-005390.hdr.sgml**: 20230120

**ACCESSION NUMBER**: 0001104659-23-005390

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20230113

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230120

**DATE AS OF CHANGE**: 20230120

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Bite Acquisition Corp.
- **CENTRAL INDEX KEY:** 0001831270
- **STANDARD INDUSTRIAL CLASSIFICATION:** BLANK CHECKS [6770]
- **IRS NUMBER:** 853307316
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40055
- **FILM NUMBER:** 23540940

**BUSINESS ADDRESS:**
- **STREET 1:** 30 WEST STREET
- **STREET 2:** NO. 28F
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10004
- **BUSINESS PHONE:** 212-608-2923

**MAIL ADDRESS:**
- **STREET 1:** 30 WEST STREET
- **STREET 2:** NO. 28F
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10004

?xml version="1.0" encoding="utf-8"?

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of report (Date of earliest event reported): January 13, 2023**

**Bite Acquisition Corp.**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-40055** | **85-3307316** |
| (State or other jurisdiction <br> of incorporation) | (Commission File Number) | (I.R.S. Employer<br> Identification No.) |

---

---

| | |
|:---|:---|
| **30 West Street, No. 28F**<br> **New York, New York**<br> (Address of principal executive offices)  | **10004**<br> (Zip Code)<br>|

---

&nbsp;&nbsp; **(212) 608-2923**<br> (Registrant's telephone number, including area code)<br>**Not Applicable**<br> (Former name or former address, if changed since last report)<br>

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

◻ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

◻ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

◻ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

◻ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| **Units, each consisting of one share of common stock, par value $0.0001 per share and one-half of one warrant** | **BITE.U** | **The New York Stock Exchange** |
| **Common stock, par value $0.0001 per share** | **BITE** | **The New York Stock Exchange** |
| **Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50** | **BITE WS** | **The New York Stock Exchange** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ⌧

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

---

| | |
|:---|:---|
| **Item 5.02** | **Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.** |

---

Mr. Jesus O. Lanza Losa has been the Founder & CEO, Education Focused Buyouts Platform of LOTTUS, Mexico since 2013, and has successfully led the acquisition, optimization, and business enlargement of six different targets totaling circa $250 million in transaction volume. Mr. Lanza Losa served as an Associate, Special Situations Group & Distressed Assets at Cerberus Capital Management, London in 2012. From 2009 to 2011, Mr. Lanza Losa was an Analyst with the Investment Banking Division – M&A LatAm at Goldman, Sachs & Co., New York/Mexico. Mr. Lanza Losa graduated from Universidad de Oviedo with a B.A. in Business Administration, and holds a Masters in Finance Degree from London Business School.

Mr. Luis Doporto is a Mexican entrepreneur with more than 20 years of experience leading specialized teams in corporate practice, domestic and international M&A, brand building and corporate strategies in pharmaceutical, agro-industrial and food & beverage sectors. In 2019, Mr. Doporto founded Doporto Prime Capital, leading a team of professionals in the beverage, pharmaceutical, finance and consumer sectors. Mr. Doporto is the CEO and Chairman of the Board of Directors of Casa Marzam, a pharmaceutical distribution company with 650 daily delivery routes and serving more than 27,000 clients in Mexico. In 2018, Mr. Doporto founded Guacamolito/Golden Stone, a U.S. company that produces and distributes avocado pulp for the food service industries. Mr. Doporto graduated from Universidad Iberoamericana and holds a Master's Degree in International Commercial Law from the Université Panthéon Assas of Paris.

---

| | |
|:---|:---|
| **Item 9.01.** | **Financial Statements and Exhibits** |

---

(c) Exhibits:

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |

---

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| **BITE Acquisition Corp.**  | **BITE Acquisition Corp.**  |
| By: | /s/ Axel Molet Warschawski |
|  | Name: Axel Molet Warschawski  |
|  | Title: Chief Financial Officer |

---

Date: January 20, 2023